Nishant N. Vaikath

2.6k total citations
30 papers, 1.3k citations indexed

About

Nishant N. Vaikath is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Nishant N. Vaikath has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Neurology, 8 papers in Physiology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Nishant N. Vaikath's work include Parkinson's Disease Mechanisms and Treatments (26 papers), Neurological disorders and treatments (14 papers) and Alzheimer's disease research and treatments (8 papers). Nishant N. Vaikath is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (26 papers), Neurological disorders and treatments (14 papers) and Alzheimer's disease research and treatments (8 papers). Nishant N. Vaikath collaborates with scholars based in Qatar, United Kingdom and Netherlands. Nishant N. Vaikath's co-authors include Omar M. A. El‐Agnaf, Nour K. Majbour, Wilma D. J. van de Berg, Mustafa T. Ardah, Takahiko Tokuda, Henk W. Berendse, Charlotte E. Teunissen, Shiji Varghese, Daniel Erskine and Stephen Poole and has published in prestigious journals such as PLoS ONE, Chemical Communications and Scientific Reports.

In The Last Decade

Nishant N. Vaikath

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nishant N. Vaikath Qatar	17	974	427	339	269	267	30	1.3k
Krisztina K. Johansen Norway	16	703 0.7×	301 0.7×	238 0.7×	194 0.7×	247 0.9×	24	933
Shiji Varghese Australia	10	809 0.8×	446 1.0×	214 0.6×	175 0.7×	148 0.6×	17	1.0k
Nicolás Méndez United States	11	668 0.7×	518 1.2×	204 0.6×	228 0.8×	353 1.3×	14	1.3k
Nour K. Majbour Qatar	21	1.5k 1.6×	668 1.6×	538 1.6×	390 1.4×	312 1.2×	36	1.9k
Dengshun Wang United States	12	728 0.7×	544 1.3×	427 1.3×	260 1.0×	269 1.0×	21	1.2k
Elvira Valera United States	22	943 1.0×	540 1.3×	557 1.6×	472 1.8×	458 1.7×	28	1.7k
Wouter Peelaerts Belgium	10	1.1k 1.1×	595 1.4×	375 1.1×	399 1.5×	340 1.3×	17	1.4k
Simon Moussaud United States	13	784 0.8×	628 1.5×	385 1.1×	340 1.3×	375 1.4×	17	1.4k
Zachary A. Sorrentino United States	18	740 0.8×	559 1.3×	320 0.9×	290 1.1×	276 1.0×	43	1.1k
Claire H. Stevens Australia	13	678 0.7×	474 1.1×	435 1.3×	440 1.6×	409 1.5×	23	1.3k

Countries citing papers authored by Nishant N. Vaikath

Since Specialization

Citations

This map shows the geographic impact of Nishant N. Vaikath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nishant N. Vaikath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nishant N. Vaikath more than expected).

Fields of papers citing papers by Nishant N. Vaikath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nishant N. Vaikath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nishant N. Vaikath. The network helps show where Nishant N. Vaikath may publish in the future.

Co-authorship network of co-authors of Nishant N. Vaikath

This figure shows the co-authorship network connecting the top 25 collaborators of Nishant N. Vaikath. A scholar is included among the top collaborators of Nishant N. Vaikath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nishant N. Vaikath. Nishant N. Vaikath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vaikath, Nishant N., et al.. (2023). Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer’s Disease. International Journal of Molecular Sciences. 24(14). 11326–11326. 4 indexed citations

Melachroinou, Katerina, Vasilios C. Constantinides, Nishant N. Vaikath, et al.. (2023). Assessment of Aggregated and Exosome-Associated α-Synuclein in Brain Tissue and Cerebrospinal Fluid Using Specific Immunoassays. Diagnostics. 13(13). 2192–2192. 8 indexed citations

El‐Agnaf, Omar M. A., Maryam Al‐Nesf, James Flynn, et al.. (2023). Uncovering a neurological protein signature for severe COVID-19. Neurobiology of Disease. 182. 106147–106147. 1 indexed citations

Islam, Zeyaul, Nishant N. Vaikath, Issam Hmila, Omar M. A. El‐Agnaf, & Prasanna R. Kolatkar. (2023). Structural insights into the unique recognition module between α‐synuclein peptide and nanobody. Protein Science. 33(2). e4875–e4875. 2 indexed citations

Vaikath, Nishant N., Indulekha P. Sudhakaran, Ilham Y. Abdi, et al.. (2022). Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers. International Journal of Molecular Sciences. 23(23). 14630–14630. 11 indexed citations

Hmila, Issam, Nishant N. Vaikath, Nour K. Majbour, et al.. (2022). Novel engineered nanobodies specific for N‐terminal region of alpha‐synuclein recognize Lewy‐body pathology and inhibit in‐vitro seeded aggregation and toxicity. FEBS Journal. 289(15). 4657–4673. 17 indexed citations

Ghanem, Simona S., Qi Zhu, Jiahong Lu, et al.. (2021). Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity. Molecules. 26(12). 3736–3736. 22 indexed citations

Majbour, Nour K., Jan Aasly, Nishant N. Vaikath, et al.. (2020). CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers. Translational Neurodegeneration. 9(1). 15–15. 47 indexed citations

Majbour, Nour K., Nishant N. Vaikath, Daniel Erskine, et al.. (2020). Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies. Neuroscience Letters. 725. 134899–134899. 14 indexed citations

10.

Gupta, Vijay, Issam Hmila, Nishant N. Vaikath, et al.. (2020). Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity. Scientific Reports. 10(1). 8137–8137. 15 indexed citations

11.

Volc, Dieter, Werner Poewe, Alexandra Kutzelnigg, et al.. (2020). Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial. The Lancet Neurology. 19(7). 591–600. 105 indexed citations

12.

Wu, Jiazhen, Mustafa T. Ardah, Caroline Haikal, et al.. (2019). Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Translational Neurodegeneration. 8(1). 18–18. 63 indexed citations

13.

Steenoven, Inger van, Nour K. Majbour, Nishant N. Vaikath, et al.. (2018). α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies. Movement Disorders. 33(11). 1724–1733. 86 indexed citations

14.

Vaikath, Nishant N., Daniel Erskine, Christopher M. Morris, et al.. (2018). Heterogeneity in α‐synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease. Neuropathology and Applied Neurobiology. 45(6). 597–608. 25 indexed citations

15.

Donadio, Vincenzo, Alex Incensi, Omar M. A. El‐Agnaf, et al.. (2018). Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study. Scientific Reports. 8(1). 14246–14246. 80 indexed citations

16.

Duffy, Megan F., Timothy J. Collier, Joseph R. Patterson, et al.. (2018). Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. Journal of Neuroinflammation. 15(1). 129–129. 140 indexed citations

17.

Majbour, Nour K., Davide Chiasserini, Nishant N. Vaikath, et al.. (2017). Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease. Scientific Reports. 7(1). 40263–40263. 45 indexed citations

18.

Majbour, Nour K., Nishant N. Vaikath, Karin D. van Dijk, et al.. (2016). Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease. Molecular Neurodegeneration. 11(1). 7–7. 204 indexed citations

19.

Vaikath, Nishant N., Nour K. Majbour, Katerina E. Paleologou, et al.. (2015). Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology. Neurobiology of Disease. 79. 81–99. 100 indexed citations

20.

Leung, Chris Wai Tung, Feng Guo, Yuning Hong, et al.. (2014). Detection of oligomers and fibrils of α-synuclein by AIEgen with strong fluorescence. Chemical Communications. 51(10). 1866–1869. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact